Clinical trial for Claudication, Intermittent
Official title Exercise Training Study of Patients With Claudicatio Intermittens
ClinicalTrials.gov ID: NCT06448390
What this study is testing
- What it's testing
- The aim of the study is to evaluate whether walking capacity in patients with intermittent claudication is improved more by home-based 5+ exercise training than by current recommendations of daily walking.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Pain in the calves after 300 m, or less measured on a treadmill
- Stable symptoms last 6 months or more
- The pain must be gone within 5 minutes after the patients stop walking
- Ankle-Brachial index at 0.7 or lower at rest
- Using statins and antiplatelet drugs since at least 3 months
You likely can't join if
- pain in the hips or elsewhere outside the calves while walking
- Remaining pain more than 5 minutes after stopped walking.
- Impossible to compress the arteries while measruing ABI or ABI lower than 0.4
- Use of statins and antiplatelet drugs less than 3 months
- symptoms less than 6 months
- Diabetes measured with HbA1c being over 48 mmol/mol (6%)
See the full eligibility criteria
- Pain in the calves after 300 m, or less measured on a treadmill
- Stable symptoms last 6 months or more
- The pain must be gone within 5 minutes after the patients stop walking
- Ankle-Brachial index at 0.7 or lower at rest
- Using statins and antiplatelet drugs since at least 3 months
- age\> 18 years
- Signed consent
- pain in the hips or elsewhere outside the calves while walking
- Remaining pain more than 5 minutes after stopped walking.
- Impossible to compress the arteries while measruing ABI or ABI lower than 0.4
- Use of statins and antiplatelet drugs less than 3 months
- symptoms less than 6 months
- Diabetes measured with HbA1c being over 48 mmol/mol (6%)
- Revascularisation the last 6 months
- Pain in the calves after longer than 300 m measured on a treadmill
- Reduced mobility in the ankles
- Reduced physical ability to perform a test on a treadmill.
- Age less than 18 years
- General conditions that impairs the ability to take part in a training study including Obesity, KOLS, heart disease, arthrosis, inflammatory joint diseases .
- No Signed consent
The study team makes the final eligibility decision.
Where it's taking place
- Ålesund, Norway
- Bergen, Norway
- Drammen, Norway
- Grålum, Norway
- Hamar, Norway
- Kristiansand, Norway
- Oslo, Norway
- Stavanger, Norway
- Trondheim, Norway
- Tønsberg, Norway
- Gothenburg, Sweden
- Linköping, Sweden
- Stockholm, Sweden
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ålesund, Norway; Bergen, Norway; Drammen, Norway; Grålum, Norway; Hamar, Norway; Kristiansand, Norway and 7 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.